Evogene Ltd. (EVGN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Evogene Ltd.

    NASDAQ: EVGN · Real-Time Price · USD
    1.25
    0.10 (8.70%)
    At close: Oct 06, 2025, 3:59 PM
    1.23
    -1.20%
    After-hours: Oct 06, 2025, 05:10 PM EDT

    Evogene Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -18.05M -25.95M -29.84M -30.45M
    Depreciation & Amortization
    		 2.5M 2.61M 2.58M 2.23M
    Stock-Based Compensation
    		 1.79M 1.88M 1.19M 2.61M
    Other Working Capital
    		 -1.17M -178K 239K 1.18M
    Other Non-Cash Items
    		 -2.64M 321K 3.08M -906K
    Deferred Income Tax
    		 9K -33K 90K 13K
    Change in Working Capital
    		 -3.31M -400K -771K 1.66M
    Operating Cash Flow
    		 -19.7M -21.58M -23.68M -24.84M
    Capital Expenditures
    		 -626K -785K -1.17M -724K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -17.15M -10.7M -911K -24.11M
    Sales Maturities Of Investments
    		 27.34M 6.92M 15.36M 4.39M
    Other Investing Acitivies
    		 58K 26K n/a n/a
    Investing Cash Flow
    		 9.62M -4.54M 13.27M -20.44M
    Debt Repayment
    		 -901K -836K 9.2M -580K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 5.43M 10.54M 125K 1.27M
    Financial Cash Flow
    		 4.66M 18.15M 9.34M 30.28M
    Net Cash Flow
    		 -5.47M -8.21M -3.35M -13.9M
    Free Cash Flow
    		 -20.33M -22.36M -24.85M -25.56M

    Add to Watchlist